Stroke, Vol 19, 401-402, Copyright © 1988 by American Heart Association
SC Fagan, FM Gengo, V Bates, SR Levine and WR Kinkel
Nimodipine is currently under investigation for the treatment of acute
stroke. Although relatively specific for the cerebrovasculature, acute
reductions in blood pressure after a dose may adversely affect neurologic
outcome. We studied 29 consecutive acute ischemic stroke patients treated
with placebo (n = 9) or either 120 (n = 10) or 240 (n = 10) mg/day of
nimodipine. Blood pressure was recorded before and 30 and 60 minutes after
a dose for the first 8 days. Ten neurologic physicians were asked to
predict the treatment group (placebo or drug) of randomly selected patients
based on blood pressure results. Only those patients on 240 mg/day of
nimodipine had significant decreases in blood pressure after a dose (p less
than 0.001); however, these were minimal (average 10 mm Hg systolic). Only
26 of 48 treatment predictions (54%) were correct. At the studied doses,
nimodipine has a minimal effect on blood pressure in the acute stroke
period.
ARTICLES
Effect of nimodipine on blood pressure in acute ischemic stroke in humans
College of Pharmacy, Wayne State University, Detroit, Michigan.
This article has been cited by other articles:
![]() |
J. Horn and M. Limburg Calcium Antagonists for Ischemic Stroke : A Systematic Review Stroke, February 1, 2001; 32(2): 570 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ahmed, P. Nasman, and N. G. Wahlgren Effect of Intravenous Nimodipine on Blood Pressure and Outcome After Acute Stroke Stroke, June 1, 2000; 31(6): 1250 - 1255. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Duncan, H. S. Jorgensen, and D. T. Wade Outcome Measures in Acute Stroke Trials : A Systematic Review and Some Recommendations to Improve Practice Stroke, June 1, 2000; 31(6): 1429 - 1438. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |